Literature DB >> 17484006

Use of fibrin glue (Tissucol) as a hemostatic in laparoscopic conservative treatment of spleen trauma.

S Olmi1, A Scaini, L Erba, A Bertolini, M Guaglio, E Croce.   

Abstract

BACKGROUND: This study aimed to evaluate the effect of fibrin glue in laparoscopic spleen-preserving procedures for traumatic rupture.
METHODS: From January 2002 to December 2005, six laparoscopic spleen-preserving procedures were performed for traumatic rupture using fibrin glue. Two of the cases had previous middle and lower abdominal surgery. Survey of the abdominal cavity was performed by inserting two 5- to 12-mm trocars, one 5-mm trocar, and a 30 degree scope. A complete survey of all the patients was performed.
RESULTS: None of the patients required laparotomy, and no postoperative bleeding occurred. The fibrin sealant achieved immediate hemostasis, and all the patients recovered without further splenic bleeding. The mean postoperative stay was 4.3 days (range, 4-5 days). All the patients were followed up for 3 to 12 months. Postoperative immunoglobulin scanning, ultrasonography, and computed tomography (CT) results were normal.
CONCLUSIONS: Laparoscopic management of spleen trauma can be used once a positive diagnosis has been made. It is useful for assessing the degree of splenic injury. A laparoscopic spleen-preserving procedure can be used safely for patients with stable vital data. It is an effective procedure for the evaluation and treatment of hemodynamically stable patients with splenic injuries for whom nonoperative treatment is controversial. The topical application of a fibrin sealant in splenic trauma achieves definitive hemostasis safely, rapidly, and reliably. It also is simple to use in either laparoscopic or open procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484006     DOI: 10.1007/s00464-007-9288-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

2.  [Minimal invasive pediatric surgery: development and progress by innovative technology].

Authors:  R T Carbon; S Baar; J Waldschmidt; H P Hümmer; S Simon
Journal:  Klin Padiatr       Date:  2001 May-Jun       Impact factor: 1.349

3.  Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy.

Authors:  N Shiraishi; Y Adachi; S Kitano; T Bandoh; T Katsuta; A Morimoto
Journal:  Br J Surg       Date:  1999-04       Impact factor: 6.939

4.  Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease.

Authors:  R A Hinder; C J Filipi; G Wetscher; P Neary; T R DeMeester; G Perdikis
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

Review 5.  Postsplenectomy infection.

Authors:  E L Francke; H C Neu
Journal:  Surg Clin North Am       Date:  1981-02       Impact factor: 2.741

6.  Management outcomes in splenic injury: a statewide trauma center review.

Authors:  T V Clancy; D G Ramshaw; J G Maxwell; D L Covington; M P Churchill; R Rutledge; D W Oller; P R Cunningham; J W Meredith; M H Thomason; C C Baker
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

7.  Prospective validation of criteria, including age, for safe, nonsurgical management of the ruptured spleen.

Authors:  J S Smith; M A Wengrovitz; B S DeLong
Journal:  J Trauma       Date:  1992-09

8.  Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma.

Authors:  M A Malangoni; L D Dillon; T W Klamer; R E Condon
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

Review 9.  Laparoscopic splenectomy: evolution and current status.

Authors:  P J Klingler; G G Tsiotos; K S Glaser; R A Hinder
Journal:  Surg Laparosc Endosc       Date:  1999-01

10.  The morbidity and mortality of splenectomy in childhood.

Authors:  S H Ein; B Shandling; J S Simpson; C A Stephens; S K Bandi; W D Biggar; M H Freedman
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

View more
  7 in total

1.  Splenic trauma in the twenty-first century: changing trends in management.

Authors:  P Roy; R Mukherjee; M Parik
Journal:  Ann R Coll Surg Engl       Date:  2018-08-16       Impact factor: 1.891

2.  Effectiveness and safety of CEUS-guided haemostatic injection for blunt splenic trauma: an animal experiment.

Authors:  W Li; J Tang; F Lv; H Zhang; S Zhang; L An
Journal:  Radiol Med       Date:  2010-07-31       Impact factor: 3.469

3.  Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an analysis of 936 procedures.

Authors:  Akshat Saxena; Winston Liauw; David L Morris
Journal:  J Gastrointest Oncol       Date:  2017-08

4.  Laparoscopic incisional hernia repair with fibrin glue in select patients.

Authors:  Stefano Olmi; Olmi Stefano; Giovanni Cesana; Cesana Giovanni; Luca Sagutti; Saguatti Luca; Claudio Pagano; Pagano Claudio; Giuseppe Vittoria; Vittoria Giuseppe; Enrico Croce; Croce Enrico
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

5.  Noninvasive management for iatrogenic splenic injury caused by chest tube insertion: a case report.

Authors:  Kazuto Ohtaka; Ryunosuke Hase; Ryohei Chiba; Mamoru Miyasaka; Shoki Sato; Yasuhito Shoji; Tatsunosuke Ichimura; Naoto Senmaru; Kichizo Kaga; Yoshiro Matsui
Journal:  Clin Case Rep       Date:  2016-10-28

Review 6.  Laparoscopic surgery for splenic injuries in the era of non-operative management: current status and future perspectives.

Authors:  Luigi Romeo; Francesco Bagolini; Silvia Ferro; Matteo Chiozza; Serafino Marino; Giuseppe Resta; Gabriele Anania
Journal:  Surg Today       Date:  2020-11-16       Impact factor: 2.549

7.  Fibrin Glue Enhances Adipose-Derived Stromal Cell Cytokine Secretion and Survival Conferring Accelerated Diabetic Wound Healing.

Authors:  Ursula Hopfner; Matthias M Aitzetmueller; Philipp Neßbach; Michael S Hu; Hans-Guenther Machens; Zeshaan N Maan; Dominik Duscher
Journal:  Stem Cells Int       Date:  2018-12-19       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.